z-logo
open-access-imgOpen Access
Fibrocytes Differ from Macrophages but Can Be Infected with HIV-1
Author(s) -
Michihiro Hashimoto,
Hesham Nasser,
Farzana Bhuyan,
Nozomi Kuse,
Yorifumi Satou,
Shigeyoshi Harada,
Kazuhisa Yoshimura,
Jun-ichi Sakuragi,
Kazuaki Monde,
Yosuke Maeda,
Sarah Welbourn,
Klaus Strebel,
Ekram W. Abd ElWahab,
M Miyazaki,
Shin-ichiro Hattori,
Nopporn Chutiwitoonchai,
Masateru Hiyoshi,
Shinichi Oka,
Masafumi Takiguchi,
Shinya Suzu
Publication year - 2015
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1500955
Subject(s) - fibrocyte , biology , macrophage , phenotype , virology , human immunodeficiency virus (hiv) , immunology , in vitro , gene , genetics
Fibrocytes (fibroblastic leukocytes) are recently identified as unique hematopoietic cells with features of both macrophages and fibroblasts. Fibrocytes are known to contribute to the remodeling or fibrosis of various injured tissues. However, their role in viral infection is not fully understood. In this study, we show that differentiated fibrocytes are phenotypically distinguishable from macrophages but can be infected with HIV-1. Importantly, fibrocytes exhibited persistently infected cell-like phenotypes, the degree of which was more apparent than macrophages. The infected fibrocytes produced replication-competent HIV-1, but expressed HIV-1 mRNA at low levels and strongly resisted HIV-1-induced cell death, which enabled them to support an extremely long-term HIV-1 production at low but steady levels. More importantly, our results suggested that fibrocytes were susceptible to HIV-1 regardless of their differentiation state, in contrast to the fact that monocytes become susceptible to HIV-1 after the differentiation into macrophages. Our findings indicate that fibrocytes are the previously unreported HIV-1 host cells, and they suggest the importance of considering fibrocytes as one of the long-lived persistently infected cells for curing HIV-1.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom